Drawing for BURST WELLNESS

USPTO serial 90584709

BURST WELLNESS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LOBO, DEBORAH E
Law office
TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with BURST WELLNESS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Patrick Sullivan

JOHN PATRICK SULLIVAN BUCHANAN INGERSOLL & ROONEY PC50 SOUTH 16TH STREET, SUITE 3200PHILADELPHIA, PA 19102UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Herbal tinctures for medical purposes; dietary supplements for humans; medicated oils containing full spectrum hemp oil; dietary beverage supplements for human consumption for therapeutic purposes; herbal bitters as a dietary supplement; herbal tonic supplements, all of the aforementioned goods containing hemp solely with a delta-9 tetrahydrocannabinol thc concentration of not more than 0.3 percent on a dry weight basis, and also containing only trace amounts of naturally occurring cbd; pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for treatment of opioid addiction with pain management; Pharmaceutical preparations for cancer tumor cell remediation; Pharmaceutical preparations, namely, antidepressants; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for cancer tumor cell remediation; Pharmaceutical preparations in the form of topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves for treating chemical imbalances, inflammation, epilepsy, depression, cancer, and opioid addiction with pain management; all of the foregoing containing or solely derived from CBD derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; anti-epileptic pharmaceutical preparations containing no CBDACTIVESep 24, 2020
044Dispensing of pharmaceuticals containing or solely derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis; Dispensing of pharmaceuticals containing no CBD; dispensing of herbal tinctures, dietary supplements for humans, medicated oils containing full spectrum hemp, dietary beverage supplements for human consumption for therapeutic purposes, herbal bitters as a dietary supplement, and herbal tonic supplementsACTIVESep 24, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 3, 2022MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 3, 2022MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 3, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 21, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2022DOCKASSIGNED TO EXAMINER—
Jun 17, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 20, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance